Nano-Mediated Fluorescence Switching for Epidermal Growth Factor Receptor Detection

Abstract

Identification of the epidermal growth factor receptor (EGFR) in biological specimens is essential for cancer diagnostics, drug development and therapeutic monitoring. However, real-time techniques for accurate EGFR expression monitoring are currently limited. In this study, we report the development of a novel nano detector (Cy3-Apt_EGFR@BPNSs) with the capabilities of quenching and recovery to enable visual EGFR expression analysis. Cy3-Apt_EGFR is a Cy3-labelled single-stranded RNA (ssRNA) that exhibits specific binding to EGFR. Black phosphorus nanosheets (BPNSs) possess the ability to adsorb Cy3-Apt_EGFR via van der Waals forces, quenching its fluorescence when combined. The detection of EGFR receptors on cancer cell surfaces prompts the release of Cy3-Apt_EGFR from BPNSs, a consequence of the robust binding interaction between the receptor and aptamer, thereby leading to fluorescence reinstatement. The recovered fluorescence intensity of this detector is found to be directly correlated with EGFR expression levels in cancer cells, indicating its potential for guiding tumour diagnosis and treatment. The specificity of Cy3-Apt_EGFR@BPNSs further enhances its utility in detecting EGFR. More importantly, our research demonstrates that the reduction in EGFR expression levels within cancer cells corresponds to a proportional decline in fluorescence intensity, thereby facilitating precise tracking of EGFR dynamics.

Keywords

aptamer / black phosphorus nanosheets (BPNSs) / cancer diagnostics / epidermal growth factor receptor (EGFR)

References

[1] E. Levantini, G. Maroni, M. Del Re, and D. G. Tenen, “EGFR Signaling Pathway as Therapeutic Target in Human Cancers,” Seminars in Cancer Biology 85 (2022): 253–275.

[2] S. Yu, A. Li, Q. Liu, et al., “Recent Advances of Bispecific Antibodies in Solid Tumors,” Journal of Hematology & Oncology 10, no. 1 (2017): 155.

[3] C. Mao and B. Gan, “Navigating Ferroptosis via an NADPH Sensor,” Nature Cell Biology 24, no. 8 (2022): 1186–1187.

[4] X. Gao, X. Xia, F. Li, et al., “Circular RNA-Encoded Oncogenic E-Cadherin Variant Promotes Glioblastoma Tumorigenicity Through Activation of EGFR-STAT3 Signalling,” Nature Cell Biology 23, no. 3 (2021): 278–291.

[5] Q. Liu, S. Yu, W. Zhao, S. Qin, Q. Chu, and K. Wu, “EGFR-TKIs Resistance via EGFR-Independent Signaling Pathways,” Molecular Cancer 17, no. 1 (2018): 53.

[6] C. Hu, C. A. Leche,, A. Kiyatkin, et al., “Glioblastoma Mutations Alter EGFR Dimer Structure to Prevent Ligand Bias,” Nature 602, no. 7897 (2022): 518–522, https://doi.org/10.1038/s41586-021-04393-3.

[7] M. Kaplan, S. Narasimhan, C. de Heus, et al., “EGFR Dynamics Change During Activation in Native Membranes as Revealed by NMR,” Cell 167, no. 5 (2016): 1241–1251.e11.

[8] A. Friedlaender, V. Subbiah, A. Russo, et al., “EGFR and HER2 Exon 20 Insertions in Solid Tumours: From Biology to Treatment,” Nature Reviews. Clinical Oncology 19, no. 1 (2022): 51–69.

[9] G. Li, Z. Song, Y. Ru, et al., “Small-Molecule Nanoprodrug With High Drug Loading and EGFR, PI3K/AKT Dual-Inhibiting Properties for Bladder Cancer Treatment,” Exploration 3, no. 5 (2023): 20220141.

[10] L. Zhong, Y. Li, L. Xiong, et al., “Small Molecules in Targeted Cancer Therapy: Advances, Challenges, and Future Perspectives,” Signal Transduction and Targeted Therapy 6, no. 1 (2021): 201, https://doi.org/10.1038/s41392-021-00572-w.

[11] A. C. Tan and D. S. W. Tan, “Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations,” Journal of Clinical Oncology 40, no. 6 (2022): 611–625.

[12] E. D. S. Santos, K. A. B. Nogueira, L. C. C. Fernandes, et al., “EGFR Targeting for Cancer Therapy: Pharmacology and Immunoconjugates With Drugs and Nanoparticles,” International Journal of Phytopharmacology 592 (2021): 120082, https://doi.org/10.1016/j.ijpharm.2020.120082.

[13] K. Shi, G. Wang, J. Pei, et al., “Emerging Strategies to Overcome Resistance to Third-Generation EGFR Inhibitors,” Journal of Hematology & Oncology 15, no. 1 (2022): 94.

[14] H. Jin, Y. Shi, Y. Lv, et al., “EGFR Activation Limits the Response of Liver Cancer to Lenvatinib,” Nature 595, no. 7869 (2021): 730–734.

[15] S. Cavallaro, P. Hååg, S. S. Sahu, et al., “Multiplexed Electrokinetic Sensor for Detection and Therapy Monitoring of Extracellular Vesicles From Liquid Biopsies of Non-Small-Cell Lung Cancer Patients,” Biosensors & Bioelectronics 193 (2021): 113568.

[16] D. Xie, Y. Li, J. Shi, et al., “A Novel Near-Infrared EGFR Targeting Probe for Metastatic Lymph Node Imaging in Preclinical Mouse Models,” Journal of Nanbiotechnology 21, no. 1 (2023): 342.

[17] J. Thariat, M. C. Etienne-Grimaldi, D. Grall, et al., “Epidermal Growth Factor Receptor Protein Detection in Head and Neck Cancer Patients: A Many-Faceted Picture,” Clinical Cancer Research 18, no. 5 (2012): 1313–1322.

[18] M. Baibarac, M. Daescu, and S. N. Fejer, “Optical Evidence for the Assembly of Sensors Based on Reduced Graphene Oxide and Polydiphenylamine for the Detection of Epidermal Growth Factor Receptor,” Coatings 11, no. 2 (2021): 258.

[19] X. Yan, Y. Song, J. Liu, et al., “Two-Dimensional Porphyrin-Based Covalent Organic Framework: A Novel Platform for Sensitive Epidermal Growth Factor Receptor and Living Cancer Cell Detection,” Biosensors & Bioelectronics 126 (2019): 734–742.

[20] S. A. Sarkis, B. H. Abdullah, B. A. Abdul Majeed, and N. G. Talabani, “Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma in Relation to Proliferation, Apoptosis, Angiogenesis and Lymphangiogenesis,” Head & Neck Oncology 2 (2010): 13.

[21] C. T. Desire, R. D. Arrua, X. L. Strudwick, Z. Kopecki, A. J. Cowin, and E. F. Hilder, “The Development of Microfluidic-Based Western Blotting: Technical Advances and Future Perspectives,” Journal of Chromatography. A 1691 (2023): 463813.

[22] P. Zhang, W. Li, C. Liu, et al., “Molecular Imaging of Tumour-Associated Pathological Biomarkers With Smart Nanoprobe: From “Seeing” to “Measuring”,” Exploration 3, no. 6 (2023): 20230070.

[23] H. S. Nourbakhsh, N. Raoufi, K. Omidfar, and M. Ardjmand, “A Sensitive Surface-Plasmon-Resonance (SPR)-Immunosensor Based on Multilayers of Graphene Oxide and Gold Nanoparticles for Epidermal Growth Factor Receptor Detection,” IEEE Sensors Journal 23, no. 1 (2022): 300–307.

[24] C. Huang, S. Hu, X. Zhang, et al., “Sensitive and Selective ctDNA Detection Based on Functionalized Black Phosphorus Nanosheets,” Biosensors & Bioelectronics 165 (2020): 112384.

[25] H. He, D. W. Sun, Z. Wu, H. Pu, and Q. Wei, “On-Off-On Fluorescent Nanosensing: Materials, Detection Strategies and Recent Food Applications,” Trends in Food Science and Technology 119 (2022): 243–256.

[26] J. Chen, D. Zhou, Z. Chen, X. Liu, Y. Xu, and L. Guo, “Enhanced Polymeric Carbon Nitride Nanosheet-Based Fluorescence for Biosensing Applications,” ACS Applied Nano Materials 6, no. 2 (2023): 1441–1447.

[27] S. He, B. Song, D. Li, et al., “A Graphene Nanoprobe for Rapid, Sensitive, and Multicolor Fluorescent DNA Analysis,” Advanced Functional Materials 20, no. 3 (2010): 453–459.

[28] C. H. Lu, H. H. Yang, C. L. Zhu, X. Chen, and G. N. Chen, “A Graphene Platform for Sensing Biomolecules,” Angewandte Chemie, International Edition in English 48, no. 26 (2009): 4785–4787.

[29] C. Tan, P. Yu, Y. Hu, et al., “High-Yield Exfoliation of Ultrathin Two-Dimensional Ternary Chalcogenide Nanosheets for Highly Sensitive and Selective Fluorescence DNA Sensors,” Journal of the American Chemical Society 137, no. 32 (2015): 10430–10436.

[30] C. Zhu, Z. Zeng, H. Li, F. Li, C. Fan, and H. Zhang, “Single-Layer MoS₂-Based Nanoprobes for Homogeneous Detection of Biomolecules,” Journal of the American Chemical Society 135, no. 16 (2013): 5998–6001.

[31] Q. Xi, D. M. Zhou, Y. Y. Kan, et al., “Highly Sensitive and Selective Strategy for microRNA Detection Based on WS₂ Nanosheet Mediated Fluorescence Quenching and Duplex-Specific Nuclease Signal Amplification,” Analytical Chemistry 86, no. 3 (2014): 1361–1365, https://doi.org/10.1021/ac403944c.

[32] X. Gui, H. Zhang, R. Zhang, et al., “Exosomes Incorporated With Black Phosphorus Quantum Dots Attenuate Retinal Angiogenesis via Disrupting Glucose Metabolism,” Materials Today Bio 19 (2023): 100602.

[33] J. Ouyang, C. Feng, X. Zhang, N. Kong, and W. Tao, “Black Phosphorus in Biological Applications: Evolutionary Journey From Monoelemental Materials to Composite Materials,” Accounts of Materials Research 2, no. 7 (2021): 489–500.

[34] Y. Sun, H. Jin, X. Jiang, and R. Gui, “Black Phosphorus Nanosheets Adhering to Thionine-Doped 2D MOF as a Smart Aptasensor Enabling Accurate Capture and Ratiometric Electrochemical Detection of Target microRNA,” Sensors and Actuators B: Chemical 309 (2020): 127777, https://doi.org/10.1016/j.snb.2020.127777.

[35] X. Ge, Z. Xia, and S. Guo, “Recent Advances on Black Phosphorus for Biomedicine and Biosensing,” Advanced Functional Materials 29, no. 29 (2019): 1900318.

[36] S. Thurakkal, D. Feldstein, R. Perea-Causín, E. Malic, and X. Zhang, “The Art of Constructing Black Phosphorus Nanosheet Based Heterostructures: From 2D to 3D,” Advanced Materials 33, no. 3 (2021): e2005254.

[37] H. Jiang, Q. Xia, J. Zheng, et al., “Mn²⁺ Modified Black Phosphorus Nanosheets With Enhanced DNA Adsorption and Affinity for Robust Sensing,” Biosensors & Bioelectronics 216 (2022): 114622.

[38] J. Zeng, L. Yang, L. Zeng, et al., “Visualizing Cancer Resistance via Nano-Quenching and Recovery Detector of CD44,” Journal of Nanbiotechnology 22, no. 1 (2024): 452.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.